Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 15, 2012 01:42 ET | Source: Evotec AG

Evotec Partners With Haplogen to Develop Drugs for Infectious Diseases

HAMBURG, Germany and VIENNA, Austria, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Haplogen GmbH have signed a collaboration agreement to discover and develop small...
November 08, 2012 01:45 ET | Source: Evotec AG

Evotec Reports 8% Revenue Growth and a Positive Operating Result of EUR 2.9 m in the First Nine Months of 2012

HAMBURG, Germany, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today reported financial results and corporate updates for the third quarter and first nine months of 2012 ending...
November 01, 2012 08:43 ET | Source: Evotec AG

Evotec to Report Results for the First Nine Months of 2012 on 08 November 2012

HAMBURG, Germany, Nov. 1, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) will report its financial results for the first nine months of 2012 on Thursday, 08 November 2012. The Company...
October 29, 2012 02:43 ET | Source: Evotec AG

Evotec Extends Ongoing Collaboration With CHDI Foundation

Collaboration aims to accelerate development of drugs that slow the progression of Huntington's disease (HD) Evotec eligible to receive up to USD 41 million HAMBURG, Germany, OXFORD,...
October 08, 2012 01:47 ET | Source: Evotec AG

Evotec Receives Milestone in Drug Discovery Collaboration

HAMBURG, Germany, Oct. 8, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has received a pre-clinical milestone from its Drug Discovery Collaboration with Novartis....
October 04, 2012 01:43 ET | Source: Evotec AG

Evotec AG: Corporate Update

HAMBURG, Germany, Oct. 4, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that Dr. Werner Lanthaler, CEO of Evotec, will temporarily stand down from his role within the...
October 01, 2012 05:09 ET | Source: Evotec AG

Evotec and Bayer Enter Into Multi-Target Alliance to Fight Endometriosis

HAMBURG, Germany, Oct. 1, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that Evotec and Bayer Pharma AG have entered into a five-year, multi-target collaboration with the...
September 28, 2012 01:50 ET | Source: Evotec AG

Evotec and Aspireo Enter Into Strategic Advisory Agreement

Teaming up to partner Aspireo's Somatoprim (DG3173) HAMBURG, Germany and TEL AVIV, Israel, Sept. 28, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Aspireo Pharmaceuticals...
September 26, 2012 01:35 ET | Source: Evotec AG

Evotec Receives Milestone Payment as Part of Its Discovery Alliance With Boehringer Ingelheim

HAMBURG, Germany, Sept. 26, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that its research alliance with Boehringer Ingelheim has reached a milestone triggering a...
September 19, 2012 01:48 ET | Source: Evotec AG

NIH Awards Major Contract to Evotec to Manage and Operate a Small Molecule Repository

NIH Small Molecule Repository HAMBURG, Germany, Sept. 19, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that Evotec has entered into a multi-year compound...